Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q1 2022 Earnings

5MayExpected

Q2 2021

Q3 2021

Q4 2021

Q1 2022

-9.25

-6.22

-3.19

-0.16

Details

Expected EPS

-0.3414

Actual EPS

-9.25

Surprise EPS

-8.91

Surprise Percent

+2,609.43%

Description

Spyre Therapeutics (SYRE) has reported earnings of -9.25 per share for Q1 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.